{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:14:57Z","timestamp":1760141697396,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.nrleng.2025.09.007","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:20:54Z","timestamp":1757031654000},"page":"777-789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence and factors associated with disability and dependency in patients with Guillain-Barr\u00e9 syndrome in the Region of Murcia: population study for the period 2009\u20132020"],"prefix":"10.1016","volume":"40","author":[{"given":"S.","family":"Rueda-Nieto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.P.","family":"Mira-Escolano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"S\u00e1nchez-Esc\u00e1mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Cayuela-Fuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.A.","family":"Maceda-Rold\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ciller-Montoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Palomar-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrleng.2025.09.007_bib0005","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1007\/s13311-021-01117-3","article-title":"Novel immunological and therapeutic insights in Guillain-Barr\u00e9 syndrome and CIDP","volume":"18","author":"Querol","year":"2021","journal-title":"Neurotherapeutics"},{"year":"2008","series-title":"S\u00edndrome de Guillain-Barr\u00e9. Protocolos Diagn\u00f3stico Terape\u00faticos de la AEP: Neurolog\u00eda Pedi\u00e1trica","author":"Pascual","key":"10.1016\/j.nrleng.2025.09.007_bib0010"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0015","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000184748","article-title":"The epidemiology of Guillain-Barr\u00e9 syndrome worldwide","volume":"32","author":"McGrogan","year":"2009","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000110301","article-title":"Incidence of Guillain-Barr\u00e9 syndrome and ganglioside intake in Alcoi, Spain","volume":"12","author":"Matias-Guiu","year":"1993","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000050769","article-title":"Guillain-Barr\u00e9 syndrome in Spain, 1985\u20131997: epidemiological and public health views","volume":"46","author":"Cuadrado","year":"2001","journal-title":"Eur Neurol"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0035","doi-asserted-by":"crossref","first-page":"705","DOI":"10.33588\/rn.3508.2002352","article-title":"S\u00edndrome de Guillain-Barr\u00e9 en el \u00e1rea norte de Gran Canaria e isla de Lanzarote","volume":"35","author":"Aladro-Benito","year":"2002","journal-title":"Rev Neurol"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0040","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1191\/0269215505cr918oa","article-title":"Disability and health-related quality of life in Guillain-Barr\u00e9 syndrome during the first two years after onset: a prospective study","volume":"19","author":"Forsberg","year":"2005","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0404.1994.tb01682.x","article-title":"Guillain-Barr\u00e9 syndrome in Cantabria, Spain. An epidemiological and clinical study","volume":"89","author":"Sedano","year":"1994","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0050","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1474-4422(07)70130-8","article-title":"A clinical prognostic scoring system for Guillain-Barr\u00e9 syndrome","volume":"6","author":"Van Koningsveld","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0055","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.nrl.2014.09.004","article-title":"Experience with Guillain-Barr\u00e9 syndrome in a neurological Intensive Care Unit","volume":"31","author":"Gonz\u00e1lez","year":"2016","journal-title":"Neurologia"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0060","doi-asserted-by":"crossref","first-page":"502","DOI":"10.33588\/rn.6411.2016503","article-title":"Polineuropat\u00edas agudas en un hospital del sur de Espa\u00f1a: diez a\u00f1os de experiencia","volume":"64","author":"Alonso Montejo","year":"2017","journal-title":"Rev Neurol"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0065","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ana.25987","article-title":"Incidence, clinical, risk factors and outcomes of Guillain-Barr\u00e9 in Covid-19","volume":"89","author":"Fragiel","year":"2021","journal-title":"Ann Neurol"},{"year":"2018","series-title":"Prevalencia de enfermedades raras en la Regi\u00f3n de Murcia 2015","author":"Mira Escolano","key":"10.1016\/j.nrleng.2025.09.007_bib0070"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0075","unstructured":"Consejer\u00eda de Salud RM. Decreto n. 223\/2015, de 16 de septiembre, por el que se establecen los criterios de gesti\u00f3n y funcionamiento del Sistema de Informaci\u00f3n sobre Enfermedades Raras de la Regi\u00f3n de Murcia. Murciasalud.es. [Accessed 27 December 2021]. Available from: http:\/\/www.murciasalud.es\/\/legislacion.php?id=331439&idsec=79."},{"key":"10.1016\/j.nrleng.2025.09.007_bib0080","unstructured":"Portal Estad\u00edstico de la Regi\u00f3n de Murcia-CREM. Carm.es. [Accessed 2 March 2023]. Available from: https:\/\/econet.carm.es\/web\/crem\/inicio\/-\/crem\/sicrem\/PU_padron\/p21\/Indice1.html."},{"key":"10.1016\/j.nrleng.2025.09.007_bib0085","unstructured":"National Institute of Neurological Disorders and Stroke. [Accessed 2 July 2023]. Available from: https:\/\/www.ninds.nih.gov\/."},{"key":"10.1016\/j.nrleng.2025.09.007_bib0090","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrneurol.2014.138","article-title":"Guillain\u2013Barr\u00e9 and Miller Fisher syndromes\u2014new diagnostic classification","volume":"10","author":"Wakerley","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0095","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.clinph.2017.03.048","article-title":"Optimizing the electrodiagnostic accuracy in Guillain-Barr\u00e9 syndrome subtypes: criteria sets and sparse linear discriminant analysis","volume":"128","author":"Uncini","year":"2017","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.2008.156463","article-title":"Recurrent Guillain-Barr\u00e9 syndrome","volume":"80","author":"Kuitwaard","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0105","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol"},{"first-page":"3","year":"2019","series-title":"Base estatal de datos de personas con discapacidad -","key":"10.1016\/j.nrleng.2025.09.007_bib0110"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0115","doi-asserted-by":"crossref","unstructured":"Ley 39\/2006, de 14 de diciembre, de Promoci\u00f3n de la Autonom\u00edaPersonal y Atenci\u00f3n a las personas en situaci\u00f3n de dependencia.BOE n\u00fam. 299, 15\/12\/2006.","DOI":"10.4321\/S1132-12962006000200007"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0120","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10072-018-3688-4","article-title":"Incidence study of Guillain-Barr\u00e9 syndrome in the province of Ferrara, Northern Italy, between 2003 and 2017. A 40-year follow-up","volume":"40","author":"Granieri","year":"2019","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0125","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s40264-020-01031-1","article-title":"Incidence rates of autoimmune diseases in European healthcare databases: a contribution of the ADVANCE project","volume":"44","author":"Willame","year":"2021","journal-title":"Drug Saf"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0130","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/brain\/awy232","article-title":"Regional variation of Guillain-Barr\u00e9 syndrome","volume":"141","author":"Doets","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0135","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/jnnp.62.5.447","article-title":"Epidemiological features of Guillain-Barr\u00e9 syndrome in Sweden, 1978\u201393","volume":"62","author":"Jiang","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0140","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/ane.13092","article-title":"A unicenter, prospective study of Guillain\u2010Barr\u00e9 syndrome in Spain","volume":"139","author":"Sedano","year":"2019","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10072-004-0231-6","article-title":"Public health surveillance and incidence of adulthood Guillain-Barr\u00e9 syndrome in Spain, 1998\u20131999: the view from a sentinel network of neurologists","volume":"25","author":"Cuadrado","year":"2004","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0150","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.nrl.2018.03.021","article-title":"Incidence and clinical characteristics of Guillain-Barr\u00e9 syndrome in Osona (Barcelona, Spain), 2003\u20132016","volume":"36","author":"Aragon\u00e8s","year":"2021","journal-title":"Neurologia (Engl Ed)"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0155","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.56.6.758","article-title":"Preceding infections, immune factors, and outcome in Guillain-Barr\u00e9 syndrome","volume":"56","author":"Hadden","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0160","doi-asserted-by":"crossref","first-page":"165","DOI":"10.20453\/rnp.v84i3.4033","article-title":"Caracter\u00edsticas cl\u00ednico-epidemiol\u00f3gicas del S\u00edndrome de Guillain Barr\u00e9 en tres hospitales de Piura, 2018\u20132019","volume":"84","author":"Solano","year":"2021","journal-title":"Rev Neuropsiquiatr"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0165","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12883-016-0598-z","volume":"16","author":"Alcalde-Cabero","year":"2016","journal-title":"BMC Neurol"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0170","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/jns.12096","article-title":"Clinical and epidemiological features of Guillain-Barr\u00e9 syndrome in the Western Balkans","volume":"19","author":"Peric","year":"2014","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0175","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/jnnp.65.2.218","article-title":"Guillain-Barr\u00e9 syndrome variants in Emilia-Romagna, Italy, 1992\u20133: incidence, clinical features, and prognosis. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology","volume":"65","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0180","first-page":"108","article-title":"Caracter\u00edsticas del s\u00edndrome de Guillain-Barr\u00e9 en el \u00e1rea III de salud de la Comunidad Aut\u00f3noma de Arag\u00f3n","volume":"25","author":"Pi\u00f1ol-Ripoll","year":"2008","journal-title":"An Med Interna"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.20453\/rnp.v80i1.3056","article-title":"Caracter\u00edsticas cl\u00ednicas y paracl\u00ednicas del S\u00edndrome de Guillain-Barr\u00e9 en el Hospital Regional Lambayeque","volume":"80","author":"Ball\u00f3n-Manrique","year":"2017","journal-title":"Rev Neuropsiquiatr"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0190","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain\u2013Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"Van den Berg","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0195","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3109\/00207454.2015.1090437","article-title":"Trends in Guillain-Barr\u00e9 syndrome mortality in Spain from 1999 to 2013","volume":"126","author":"Ruiz","year":"2016","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0200","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.nrl.2018.06.002","article-title":"Axonal pathology in early stages of Guillain-Barr\u00e9 syndrome","volume":"37","author":"Berciano","year":"2022","journal-title":"Neurologia (Engl Ed)"},{"key":"10.1016\/j.nrleng.2025.09.007_bib0205","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12974-021-02301-0","article-title":"Autoantibody screening in Guillain-Barr\u00e9 syndrome","volume":"18","author":"Lleix\u00e0","year":"2021","journal-title":"J Neuroinflammation"}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580825000884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580825000884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:15:27Z","timestamp":1760069727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173580825000884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2173580825000884"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2025.09.007","relation":{},"ISSN":["2173-5808"],"issn-type":[{"type":"print","value":"2173-5808"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and factors associated with disability and dependency in patients with Guillain-Barr\u00e9 syndrome in the Region of Murcia: population study for the period 2009\u20132020","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2025.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2023.08.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}